What does a CAP mock inspection actually cover?

A Bench Standard mock inspection simulates a real CAP survey day. We use the current edition of the All Common, Laboratory General, and discipline-specific checklists; score every applicable item; observe staff in real workflow; and deliver a written findings report categorized as Critical, Major, or Minor with corrective-action deadlines mapped to specific checklist items. The methodology is anchored to CAP's Laboratory Accreditation Program inspection process and 42 CFR §493.1230 series quality system requirements.

How long does a CAP rapid readiness engagement take?

Two to four weeks for a Mock Inspection engagement (typical), four to six weeks for a Competency Assessment Program build, and four to eight weeks for a QC Program Design engagement. Each timeline is published, fixed, and stated on the service page before you sign.

What are the six elements of CLIA competency assessment?

Per 42 CFR §493.1451(b)(8): direct observation of routine patient testing; monitoring the recording and reporting of test results (including intermediate results, QC records, proficiency testing records, and preventive maintenance records); direct observation of instrument maintenance and function checks; assessment via previously analyzed specimens, internal blind samples, or external proficiency testing samples; problem-solving skill assessment; and evaluation of analytical interpretation skill. All six are required — not optional, not selectable.

Who can perform competency assessments under CLIA?

For high-complexity testing personnel, the technical supervisor (TS) is the assessor of record, with delegation rules defined under 42 CFR §493.1451. For moderate-complexity testing, the technical consultant (TC) is the analog assessor under 42 CFR §493.1413(b)(8). Delegation must be documented; the TS retains responsibility regardless of who performs the observation.

When did CMS stop sending paper CLIA certificates?

Effective March 1, 2026. After that date CMS does not issue paper certificates or mail fee coupons. All CLIA fees flow through Pay.gov; certificates and inspection notices arrive via the email address of record. Labs must (1) register a monitored email, (2) add CMS to the safe-senders list, and (3) ensure CMS-116 elects electronic communication.

CMS-3326-F is the CLIA final rule published December 28, 2023 (Fed. Reg. doc. 2023-28170) that updated personnel qualifications under 42 CFR Part 493 Subpart M, effective December 28, 2024. It changed the educational and experience requirements for laboratory director, technical consultant, technical supervisor, clinical consultant, general supervisor, and testing personnel. (Note: CMS-3355-F is a separate, earlier rule covering CLIA proficiency testing analytes, not personnel.)

What are the required elements of a CAP-compliant SOP?

The minimum element set under CLSI QMS01-Ed5 (formerly GP26) is: title, purpose, scope, principle, specimen requirements, reagents and materials, quality control, calibration, procedural steps, results reporting, expected values, calculations, limitations, safety, references, and a document-control footer. CAP All Common GEN.20377 enforces biennial review with director signature.

How often do laboratory SOPs need to be reviewed?

At minimum biennially under CAP All Common GEN.20377, with director or designee signature dating each review. Whenever a method changes, an instrument changes, a reagent lot changes in a way that affects the SOP, or a regulatory advisory affects the procedure, the SOP must be revised — not just re-signed.

What are Westgard rules and which ones should our lab use?

Westgard rules are multi-rule statistical control procedures (1-3s, 2-2s, R-4s, 4-1s, 10x, etc.) that combine to balance error detection against false rejection. The right combination depends on the analyte's sigma metric — high-sigma methods need fewer rules; low-sigma methods need tighter rules. The program selects rules per analyte from the lab's actual performance data.

The Individualized Quality Control Plan is a CMS-recognized QC pathway under 42 CFR §493.1256 that allows the lab, after a documented risk assessment, to use the manufacturer's recommended QC frequency rather than the default external QC frequency.

What is the difference between RUO and clinical testing under CLIA?

Research-use-only (RUO) testing is performed for research purposes only and is not used to make patient management decisions. Clinical testing under CLIA generates results used for diagnosis, treatment, or management of a patient. The CLIA program applies to clinical testing — every clinical specimen run for billing or clinical use requires the lab to hold an appropriate CLIA certificate.

What is an LDT and how is it validated?

A Laboratory Developed Test is a test designed, manufactured, and used within a single CLIA-certified high-complexity laboratory. Under CLIA, LDTs require analytical validation covering accuracy, precision, sensitivity, specificity, reportable range, and reference intervals; high-complexity LDTs also require clinical performance characteristics.

Is hourly billing available?

No. Every engagement is fixed-fee against a written scope. Hourly billing misaligns incentives. Invoicing is 50% at engagement start and 50% at delivery, net 15.

What is the difference between this and hiring a compliance officer?

A dedicated compliance FTE costs $90,000–$140,000 fully loaded in the DMV market. The Monthly Compliance Retainer at $1,500–$3,000/month covers regulatory monitoring, SOP review cycle, and competency-program oversight — at $18,000–$36,000 annually. The retainer does not provide on-site daily presence; for labs that need expertise but not daily presence, the retainer replaces the FTE.

Why does the consultant being active on the bench matter?

Compliance is downstream of operations. A consultant who has not run a bench in five years writes recommendations that look right on paper but break the actual workflow. Active bench experience keeps the recommendations operational — they survive contact with a Saturday short-staffed shift.

Do you work with biotech startups in Maryland's I-270 corridor?

Yes. Startup Lab Consulting ($5,000–$10,000) covers the regulatory pathway from research-use-only to CLIA-certified clinical testing, including certificate type selection, personnel qualifications under 42 CFR Part 493 Subpart M, and Maryland-specific permit guidance under COMAR 10.10.03 (Medical Laboratories—Licenses).

CLIA Personnel Qualifications Changed in 2025: Is Your Staff Still Compliant?

Ugochi Ndubuisi
Apr 18
2 min read

The CMS-3355-F final rule, effective December 28, 2024, modernized CLIA personnel qualifications for the first time in decades. Then in June 2025, QSO-25-21-CLIA added enforcement discretion that softened some of the new requirements. If you haven't reviewed your personnel files since these changes took effect, you may have a compliance gap you don't know about.

What Changed Under CMS-3355-F

The final rule updated personnel qualification pathways for several key roles, including laboratory directors, technical supervisors, clinical consultants, and general supervisors. It also updated CLIA fee structures. The most significant changes affect how individuals qualify for these roles — particularly the education and experience combinations that CMS now accepts.

For laboratory directors under §493.1405(b)(2), the updated rule modified the experience and continuing education requirements. Technical consultant and clinical consultant pathways were also adjusted to reflect the current workforce reality — recognizing that the field has evolved since the original CLIA regulations were written.

QSO-25-21-CLIA: The Enforcement Discretion Memo

In June 2025, CMS issued QSO-25-21-CLIA, which provides enforcement discretion on some of the new personnel requirements. The key provisions:

Lab Directors under §493.1405(b)(2) may now qualify with EITHER 1 year of experience OR 20 CE credits — not both, as originally specified in the final rule.
Previously qualified clinical consultants and high-complexity directors are exempt from the additional 20 CE credit requirement.
This enforcement discretion is active now but has no stated end date — labs should track CMS updates for changes.

What You Should Do Now

Pull every personnel file for staff in qualifying roles: laboratory director, technical supervisor, clinical consultant, general supervisor, and testing personnel.
Verify that each person's qualifications meet the current requirements under CMS-3355-F as modified by QSO-25-21-CLIA.
Document your verification — this is what surveyors will ask for. A simple spreadsheet mapping each person to the specific regulatory pathway they qualify under is sufficient.
Update your personnel SOPs to reference the current regulatory citations, not the old ones.
Set a calendar reminder to check for updates to QSO-25-21-CLIA enforcement discretion, since CMS could modify or withdraw it.

The Risk of Doing Nothing

Personnel qualification deficiencies are not minor findings. A laboratory director who doesn't meet the current requirements can trigger a condition-level deficiency — the most serious category, which can jeopardize your CLIA certificate and halt Medicare reimbursement. The stakes are too high to assume your files are current just because nobody has checked recently.

We Can Help

Bench Standard Consulting offers CLIA Personnel Credential Reviews starting at $2,000. We audit every qualifying role against the current CMS-3355-F requirements, document the findings, and provide a corrective action plan for any gaps. The engagement typically takes 1–2 weeks.

Book a free discovery call to discuss your lab's personnel compliance.